Cargando…
On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines
Over the past 60 years, the Mycobacterium bovis bacille Calmette–Guérin (BCG) has been used worldwide to prevent tuberculosis (TB). However, BCG has shown a very variable efficacy in different trials, offering a wide range of protection in adults against pulmonary TB. One of the most accepted hypoth...
Autores principales: | Arregui, Sergio, Sanz, Joaquín, Marinova, Dessislava, Martín, Carlos, Moreno, Yamir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756732/ https://www.ncbi.nlm.nih.gov/pubmed/26893956 http://dx.doi.org/10.7717/peerj.1513 |
Ejemplares similares
-
Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines
por: Tovar, Mario, et al.
Publicado: (2019) -
Data-driven model for the assessment of Mycobacterium tuberculosis transmission in evolving demographic structures
por: Arregui, Sergio, et al.
Publicado: (2018) -
Projecting social contact matrices to different demographic structures
por: Arregui, Sergio, et al.
Publicado: (2018) -
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
por: Aguilo, Nacho, et al.
Publicado: (2016) -
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
por: Gonzalo-Asensio, Jesus, et al.
Publicado: (2017)